ID   MM9H-1
AC   CVCL_C6JG
DR   CCRID; 4201PAT-CCTCC01838
DR   Wikidata; Q116049793
RX   Patent=CN113201494B;
RX   PubMed=35666052;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C202174.
CC   Population: Chinese.
CC   Doubling time: ~36 hours (PubMed=35666052).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
DI   NCIt; C5915; Oral cavity mucosal melanoma
DI   ORDO; Orphanet_168999; Malignant melanoma of the mucosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 5
//
RX   PubMed=35666052; DOI=10.1002/cac2.12315; PMCID=PMC9257989;
RA   Shi, Chao-Ji
RA   Gu, Zi-Yue
RA   Xu, Sheng-Ming
RA   Ju, Hou-Yu
RA   Wu, Yun-Teng
RA   Han, Yong
RA   Li, Jia-Yi
RA   Li, Chang-Wei
RA   Wu, Jing
RA   Wang, Li-Zhen
RA   Li, Jiang
RA   Zhou, Guo-Yu
RA   Ye, Wei-Min
RA   Ren, Guo-Xin
RA   Zhang, Zhi-Yuan
RA   Zhou, Rong
RT   "Candidate therapeutic agents in a newly established triple wild-type
RT   mucosal melanoma cell line.";
RL   Cancer Commun. (Lond.) 42:627-647(2022).
//
RX   Patent=CN113201494B;
RA   Shi, Chao-Ji
RA   Gu, Zi-Yue
RA   Zhou, Rong
RA   Xu, Sheng-Ming
RA   Han, Yong
RA   Ren, Guo-Xin
RA   Zhang, Zhi-Yuan
RT   "Mucosal melanoma cell and application thereof.";
RL   Patent number CN113201494B, 21-Apr-2023.
//